Further research revealed that elevated CRIP1 was closely correlated with a higher pathological stage, grade, and positive lymphatic metastasis of patients, pointing to a link between increased CRIP1 expression and ovarian cancer aggressiveness. Here, CRIP1 is linked to ovarian carcinoma.